Position in MYGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$529,159
-$1,167,373 QoQ
Shares Held
117,591
-57.4% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,136,235,129 across 32 Diagnostics & Research names. MYGN ranks #28 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
611,950 | $300,791,783 | |
| 2 | DHR |
Danaher Corp /De/
|
1,012,199 | $191,912,930 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
173,731 | $97,617,711 | |
| 4 | ILMN |
Illumina, Inc.
|
609,802 | $75,164,194 | |
| 5 | A |
Agilent Technologies, Inc.
|
499,389 | $56,920,358 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
324,104 | $55,272,696 | |
| 7 | WAT |
Waters Corp /De/
|
178,037 | $53,019,418 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
42,022 | $52,998,146 |
All Filings in MYGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $529,159 | 117,591 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,696,532 | 275,859 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,097,025 | 290,045 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,619,066 | 304,909 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,470,064 | 278,474 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $3,969,072 | 289,502 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $7,596,835 | 277,358 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,932,820 | 283,435 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $5,898,689 | 276,674 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $5,191,189 | 271,222 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $4,319,684 | 269,307 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $6,212,100 | 267,994 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $6,248,266 | 268,974 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,739,110 | 257,692 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,705,757 | 246,633 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $4,317,246 | 237,603 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,721,433 | 227,041 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $6,288,025 | 227,827 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $7,435,418 | 230,270 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,846,889 | 256,602 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $8,060,145 | 264,701 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $5,235,313 | 264,811 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $3,076,266 | 235,910 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,846,181 | 250,986 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,803,211 | 265,773 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||